New York State Teachers Retirement System decreased its position in shares of Balchem Corporation (NASDAQ:BCPC - Free Report) by 5.8% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 44,199 shares of the basic materials company's stock after selling 2,700 shares during the period. New York State Teachers Retirement System owned 0.14% of Balchem worth $7,337,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other hedge funds have also bought and sold shares of BCPC. Quadrant Capital Group LLC boosted its holdings in Balchem by 8.2% during the fourth quarter. Quadrant Capital Group LLC now owns 989 shares of the basic materials company's stock worth $161,000 after buying an additional 75 shares in the last quarter. Covestor Ltd increased its position in Balchem by 93.8% during the fourth quarter. Covestor Ltd now owns 157 shares of the basic materials company's stock worth $26,000 after purchasing an additional 76 shares during the last quarter. Arizona State Retirement System increased its position in Balchem by 0.8% during the fourth quarter. Arizona State Retirement System now owns 9,413 shares of the basic materials company's stock worth $1,534,000 after purchasing an additional 77 shares during the last quarter. Vident Advisory LLC increased its position in Balchem by 6.0% during the fourth quarter. Vident Advisory LLC now owns 1,421 shares of the basic materials company's stock worth $232,000 after purchasing an additional 80 shares during the last quarter. Finally, Heritage Family Offices LLP increased its position in shares of Balchem by 5.9% during the first quarter. Heritage Family Offices LLP now owns 1,504 shares of the basic materials company's stock valued at $250,000 after acquiring an additional 84 shares during the last quarter. Institutional investors and hedge funds own 87.91% of the company's stock.
Analyst Ratings Changes
A number of brokerages recently weighed in on BCPC. HC Wainwright set a $180.00 price objective on shares of Balchem and gave the company a "buy" rating in a report on Monday, April 28th. Wall Street Zen cut shares of Balchem from a "buy" rating to a "hold" rating in a report on Wednesday, May 21st.
Get Our Latest Stock Report on Balchem
Balchem Stock Down 1.0%
Balchem stock traded down $1.68 during trading on Monday, reaching $163.34. The stock had a trading volume of 45,870 shares, compared to its average volume of 142,736. Balchem Corporation has a 52-week low of $145.70 and a 52-week high of $186.03. The business has a 50 day moving average price of $163.40 and a 200 day moving average price of $163.03. The company has a quick ratio of 1.40, a current ratio of 2.44 and a debt-to-equity ratio of 0.18. The stock has a market cap of $5.33 billion, a PE ratio of 39.11, a P/E/G ratio of 3.56 and a beta of 0.89.
Balchem (NASDAQ:BCPC - Get Free Report) last issued its quarterly earnings data on Thursday, April 24th. The basic materials company reported $1.22 earnings per share for the quarter, missing the consensus estimate of $1.25 by ($0.03). The company had revenue of $250.52 million for the quarter, compared to analysts' expectations of $245.70 million. Balchem had a return on equity of 12.01% and a net margin of 14.16%. The firm's quarterly revenue was up 4.5% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.03 EPS. On average, analysts predict that Balchem Corporation will post 4.64 EPS for the current year.
Balchem Profile
(
Free Report)
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.
Featured Articles

Before you consider Balchem, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Balchem wasn't on the list.
While Balchem currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.